Resveratrol regulates Thoc5 to improve maternal immune activation-induced autism-like behaviors in adult mouse offspring. 2024

Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
Department of Child and Adolescent Health, Public Health College, Harbin Medical University, Harbin, 150081, China.

Maternal infection during pregnancy is an important cause of autism spectrum disorder (ASD) in offspring, and inflammatory infiltration caused by maternal immune activation (MIA) can cause neurodevelopmental disorders in the fetus. Medicine food homologous (MFH) refers to a Traditional Chinese Medicine (TCM) concept, which effectively combines food functions and medicinal effects. However, no previous study has screened, predicted, and validated the potential targets of MFH herbs for treating ASD. Therefore, in this study, we used comprehensive bioinformatics methods to screen and analyze MFH herbs and drug targets on a large scale, and identified resveratrol and Thoc5 as the best small molecular ingredient and drug target, respectively, for the treatment of MIA-induced ASD. Additionally, the results of in vitro experiments revealed that resveratrol increased the expression of Thoc5 and effectively inhibited lipopolysaccharide-induced inflammatory factor production by BV2 cells. Moreover, in vivo, resveratrol increased the expression of Thoc5 and effectively inhibited placental and fetal brain inflammation in MIA pregnancy mice, and improved ASD-like behaviors in offspring.

UI MeSH Term Description Entries

Related Publications

Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
April 2021, International journal of environmental research and public health,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
June 2021, Nature neuroscience,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
September 2020, Behavioural brain research,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
August 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
April 2020, Experimental animals,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
April 2020, Cells,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
March 2024, Physiology & behavior,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
September 2022, Translational psychiatry,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
April 2019, Autism research : official journal of the International Society for Autism Research,
Xin Zeng, and Linlin Fan, and Mengyue Li, and Qian Qin, and Xiuming Pang, and Shanyi Shi, and Danyang Zheng, and Yutong Jiang, and Han Wang, and Lijie Wu, and Shuang Liang
May 2012, Brain, behavior, and immunity,
Copied contents to your clipboard!